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ANASETTI INSTALLED AS PRESIDENT;
WEISDORF ELECTED VICE PRESIDENT
Claudio Anasetti, MD, has been in-
stalled as president of the American
Society for Blood and Marrow Trans-
plantation. He is a professor of oncol-
ogy and medicine, and chair of the
Blood and Marrow Transplant Depart-
ment at the University of South Florida
in Tampa.
Daniel J. Weisdorf, MD, professor of
medicineat theUniversityofMinnesota
in Minneapolis, is the newly elected
and installed vice president, to become
president in 2011. He also is director of
the University of Minnesota’s Adult
Blood and Marrow Transplant Pro-
gram, and is scientific director for the
National Marrow Donor Program and
senior research advisor for the CIBMTR.
Installed as treasurer was Stephanie
J. Lee, MD, MPH, an associate profes-
sor of medicine at the Fred Hutchinson
Cancer Research Center in Seattle.
The installation of new officers and
directors occurred at the society’s an-
nual meeting, the BMT Tandem Meet-
ings, on Feb. 14 in San Diego. The
election was by ballot among mem-
bers of the society in December and
January.
Newly elected and installed direc-
tors are:
 Karen Ballen, MD, of Harvard Med-
ical School and Massachusetts Gen-
eral Hospital in Boston
 James L. Gajewski, MD, of Oregon
Health & Science University, Port-
land
 James W. Young, MD, of Weill-Cor-
nell Graduate School of Medical
Sciences and Memorial Sloan-Ket-
tering Cancer Center in New York
All took office at the close of the
BMT Tandem Meetings.
A. John Barrett, MD, was elevated
to president-elect and will assume
the presidency in 2010. He is section
chief for stem cell allotransplantation
in the Hematology Branch of the
NIH National Heart Lung and Blood
Institute, Bethesda, Md.The new ASBMT president, Dr.
Anasetti, earned his M.D. in internal
medicine at the University of Perugia
School of Medicine, Italy, and com-
pleted fellowships in immunology at
Children’s Memorial Hospital, Okla-
homa City, and in oncology at the
Fred Hutchinson Cancer Research
Center, Seattle. He was named direc-
tor of the Unrelated Donor Marrow
Transplant Program at Fred Hutchin-
son in 1990. He was appointed chief
of the Blood and Marrow Transplant
Division at Moffitt Cancer Center and
Research Institute in 2004.
Dr. Anasetti is chair of the BMT Clini-
cal Trial Network study of Peripheral
Blood Stem Cells vs. Marrow Grafts
from Unrelated Donors. He has been
president of the National Marrow Do-
nor Program and a member of the
NIH Cancer Immunopathology and
Immunotherapy Study Section. He
was ASBMT scientific program chair
for the 2006 BMT Tandem Meetings
in Honolulu, has chaired the ASBMT
Scientific Affairs Council, and has
served on the ASBMT Board of Direc-
tors since 2004. He is a member of
the Editorial Board of Biology of Blood
and Marrow Transplantation.TWO NEW INVESTIGATORS WIN
BBMT EDITORIAL AWARDS
Two medical scientists are the recipi-
ents of editorial awards for new investi-
gators for their articles published this
past year in Biology of Blood and
Marrow Transplantation.
Both are recipients of a $5,000
prize, supported by grants from Stem-
Cell Technologies Inc., and StemSoft
Software Inc. Selection of the winning
articles was by the BBMT Editorial
Board and the ASBMT Publications
Committee.
William H.D. Hallett, PhD, of the
University of Nevada School of Medi-
cine, Reno, is winner of the Ernest
McCulloch & James Till Award for
best basic science article by a new in-
vestigator. The award is supportedby an education grant from StemCell
Technologies Inc.
His article, published in the October
2008 issue, was ‘‘Combination Ther-
apy Using IL-2 and Anti-CD25 Results
in Augmented Natural Killer Cell-Medi-
ated Antitumor Responses.’’
Xupeng Ge, MD, PhD, of Massachu-
setts General Hospital and Harvard
Medical School, Boston, is recipient of
the George Santos Award for best clini-
cal science article by a new investigator.
The award is supported by an educa-
tion grant from Stemsoft Software Inc.
His article published in the May
2008 issue was ‘‘CD134-Allodepletion
Allows Selective Elimination of Allor-
eactive Human T Cells without Loss
of Virus-Specific and Leukemia-Specific
Effectors.’’
The awards were presented at the
2009 BMT Tandem Meetings in Tampa.LIFETIME ACHIEVEMENT AWARD
GIVEN TO GEORGIA VOGELSANG
The 2009 recipient of the ASBMT
Lifetime Achievement Award is Geor-
gia Vogelsang, MD, of Johns Hopkins
University, Baltimore.
Dr. Vogelsang was recognized for
her trailblazing work in the area of
chronic GVHD and also for her dedica-
tion to mentorship and collaborative
research. She is the first female
recipient since the award was estab-
lished in 2000.
Dr. Vogelsang graduated from
Georgetown University in 1976 in
only the second class of women ad-
mitted to the College of Arts and Sci-
ences. She then enrolled in medical
school at Johns Hopkins where she
has remained ever since. Her involve-
ment in graft-vs.-host disease research
started when she was a fellow work-
ing with Drs. Alan Hess and George
Santos. She was one of the early trans-
lational researchers, spending part of
her time trying to give rodents
GVHD or cure them of it, and part of
her time making clinical observations
and running clinical trials. She was651
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lished a multidisciplinary clinic model
where patients could obtain thor-
ough evaluations by multiple subspe-
cialists. Many such clinics exist today.
‘‘At that time, we were a small group
of women in transplantation that in-
cluded Jean Sanders, Norma Ramsey,
Nancy Kernan, Jean Hensley Downey,
Jane Apperley and Eliane Gluckman,’’
she said. ‘‘I wish I could share this
award with all these women for their
leadership.’’
Dr. Vogelsang has participated in
the development of many of the
agents in today’s GVHD therapeutic
armamentarium. She was involved in
some of the first publications about
thalidomide, rapamycin, mycopheno-
late mofetil, PUVA, pulse steroids and
pentostatin for treatment of chronic
GVHD. She is known to her col-
leagues as a genuine collaborator.
She also has mentored many trainees
at all levels, from high school students
to mid-level faculty. She held a K24
mentoring award for 10 years.
For the past five years, Dr. Vogelsang
has been at the center of a resurgence
of research interest in GVHD. She
helped bring together diverse investi-
gators for an NIH consensus confer-
ence in 2005 to advance clinical trials
in chronic GVHD. She also just finished
editing a 35-chapter textbook, the first
ever devoted to chronic GVHD.
Her continued commitment and in-
volvement in the field may be all the
more remarkable because of her own
personal tragedy – a serious bicycle acci-
dent about 10 years ago. Her disability
prevented her from attending theASBMT President’s Dinner where the
award was presented at the BMT Tan-
dem Meetings in February in Tampa.
Ina statementdeliveredat thedinner,
Dr. Vogelsang said that ‘‘if an award is
given to recognize the advancements
in the field of chronic GVHD, personally
I feel that it should be shared with Keith
Sullivan, Paul Martin, Steve Pavletic,
Stephanie Lee, Mary Flowers, Andy
Gilman and Gerard Socie.
‘‘Together we have made progress,
but much remains to be done. There
is now a flowering of interest in the
immunology of chronic GVHD and
the field is attracting some of the
best and brightest in the field of trans-
plantation – both in the laboratory
and in the clinic.
‘‘Thank you to the society for this
honor. I accept it on behalf of the
many who have spent their careers
trying to help others. The future is
bright indeed.’’
The ASBMT Lifetime Achievement
Award is supported by Pfizer Inc.SIX ABSTRACTS CHOSEN AS BEST
OF 2009 BMT TANDEM MEETINGS
A total 470 abstracts from 29 coun-
tries were accepted for the 2009 BMT
Tandem Meetings.
Six of the abstracts were selected for
awards by the abstract review com-
mittees.
Recipients of the ASBMT Best
Abstract Awards for Basic Science
Research were:
 Valentina Hoyos, MD, Baylor College
of Medicine, Houston – EngineeringCD19-Redirected T Lymphocytes to
Enhance Their Safety and Efficacy
 Olaf Penack, MD, Memorial Sloan-
Kettering Cancer Center, New York
– Depletion of Vascular Endothelial
Progenitor Cells Simultaneously
Ameliorates GVHD and Inhibits
Tumor Growth
 Jaebok Choi, PhD, Washington Uni-
versity, Washington University
School of Medicine – Epigenetic
Modulation of Foxp3: Generation
of CD4+CD25- T Cells with a Sup-
pressor Phenotype
Each received a $1,000 prize.
Recipients of the CIBMTR Best Ab-
stract Awards for Clinical Research
were:
 Sarah Cooley, MD, University of Min-
nesota, Minneapolis – The Relapse-
Free Survival Benefit Associated
withGroup B KIR Haplotype Donors
for Unrelated Hematopoietic Cell
Transplantation Is Unique to Acute
Myelogenous Leukemia
 Margaret L. MacMillan, MD, Univer-
sity of Minnesota, Minneapolis –
Alternate Donor HCT for Fanconi
Anemia (FA): Results of a Total
Body Irradiation (TBI) Dose De-
Escalation Study
 Peter J. Shaw, MBBS, Children’s
Hospital at Westmead, Syndey,
Austrial – Pediatric BMT for Malig-
nancy Using Zero/One Antigen
Mismatched Family Donors or Un-
related Donors Have Similar Out-
comes, Both of Which Are Inferior
to Matched Sibling Donors
Each also received a $1,000 prize.
The clinical research awards are sup-
ported by a grant from CaridianBCT.
